NCT05534893

Brief Summary

This research study will test the effects of Blueberries on immune functions in overweight older men and postmenopausal women

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 10, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

October 12, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 12, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 12, 2023

Completed
Last Updated

February 4, 2026

Status Verified

February 1, 2026

Enrollment Period

11 months

First QC Date

September 6, 2022

Last Update Submit

February 2, 2026

Conditions

Keywords

BlueberriesImmunityInflammation

Outcome Measures

Primary Outcomes (5)

  • changes in lymphocyte populations

    Immunophenotyping will be performed by flow cytometry to measure the number of T helper, T cytotoxic, Naïve and memory cells and B cells

    baseline to 12 weeks

  • changes in cytokine production

    PBMC cells will be separated from blood, activated and cultured using phytohemagglutinin (PHA). Inflammatory cytokine production will be measured in the resulting supernatant using ELISA

    baseline to 12 weeks

  • changes in natural killer (NK) cell activity

    The NK degranulation assay will be performed on blood samples. The test will be conducted using a modified flow cytometry method that measures the expression of CD107a

    baseline to 12 weeks

  • changes in serum inflammatory cytokine concentration

    Changes in the concentrations of the inflammatory cytokines will be performed on serum using enzyme-linked immunoassay (ELISA)

    baseline to 12 weeks

  • changes in complete blood count (CBC)

    changes in the complete blood count will be performed on whole blood with the use of an automated hematology analyzer at a certified clinical facility

    baseline to 12 weeks

Study Arms (2)

Blueberry powder group

EXPERIMENTAL

Participants in the blueberry powder group will receive freeze dried blueberries in form of a powder

Dietary Supplement: Blueberry powder groupDietary Supplement: Placebo powder group

Placebo powder group

PLACEBO COMPARATOR

Participants in the placebo group will receive an isocaloric placebo powder.

Dietary Supplement: Blueberry powder groupDietary Supplement: Placebo powder group

Interventions

Blueberry powder groupDIETARY_SUPPLEMENT

Participants in the blueberry powder group will receive freeze dried blueberries in form of a powder

Blueberry powder groupPlacebo powder group
Placebo powder groupDIETARY_SUPPLEMENT

Participants in the placebo powder group will receive an isocaloric placebo powder

Blueberry powder groupPlacebo powder group

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older men and post-menopausal women aged 50-70 year
  • Have BMI of 25-32
  • Able to commute to Loma Linda University
  • Consuming a typical American Diet low in polyphenols

You may not qualify if:

  • Intolerance or allergy to Blueberries
  • Regular intake of Blueberries and other berried (\>2 ounces/week)
  • Immune system insufficiency or disease
  • Using immune boosting supplements
  • Exposure to antibiotics and corticoids immediately prior to study
  • Uncontrolled chronic diseases and relevant psychiatric illness, including major depression
  • Flu vaccination and or Covid Vaccination less than 3 months ago from the start of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loma Linda University School of Public Health

Loma Linda, California, 92350, United States

Location

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Joan Sabate, DrPH

    Loma Linda University

    PRINCIPAL INVESTIGATOR
  • Sujatha Rajaram, PhD

    Loma Linda University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The investigator, participant, care provider, outcomes assessor will not be aware of which participant is in which arm
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This will be a parallel, free-living, randomized controlled trial, where 52 overweight men and postmenopausal women will be randomized to receive either the freeze dried blueberries or a placebo powder
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2022

First Posted

September 10, 2022

Study Start

October 12, 2022

Primary Completion

September 12, 2023

Study Completion

September 12, 2023

Last Updated

February 4, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations